Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Positive Technologies shipments increased 2% in 9 months

11/7/24 POSI

Positive Technologies reported for 9 months of 2024 by IFRS

11/7/24 POSI

Positive Technologies reported for 9 months of 2024 by RAS

11/7/24 POSI

Lukoil denies agreements to sell refinery to Bulgaria

11/7/24 LKOH

Trading on the stock market will start at noon

11/7/24 MOEX

Globaltrans to finalize repurchase of receipts

11/7/24 GLTR

Start of trading on the Stock Market is postponed

11/7/24 MOEX

Mikhail Kenin is looking for a buyer for his stake in Samolet

11/7/24 SMLT

Board of Directors of Renaissance Insurance recommended dividends

11/7/24 RENI

SFI's Board of Directors raised the dividend for the first 9 months of 2024

11/6/24 SFIN